Joint venture agreement with NIP B.V., a wholly owned undertaking of NIZO Food Research

摘要

OptiBiotix Health plc (AIM: OPTl), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces that it has entered into a 50/50 joint venture agreement with NIP B.V., a wholly owned undertaking of NIZO Food Research BV. As announced in October 2014, OptiBiotix incorporated its weight management formulation into fruit yoghurts which were manufactured by NIZO. An organoleptic (tasting) panel reported the yoghurt products had a smooth feel and taste and had the appearance of conventional yoghurts. These results have led to this JV agreement which has been established to develop, manufacture and distribute (both directly and indirectly) the weight management yoghurt and other dairy products to global markets. NIZO provides manufacturing expertise, industry credibility and a global network of contacts in the dairy industry. This agreement will allow OptiBiotix to fast-track entry into global markets. Both companies are contributing background intellectual property (IP), with any new IP jointly owned.